I'm not talking about what Myllan has said in any CP they can state whatever they want in them.
What I'm referring to it your repeated statements that the FDA has two sets of guidlines when approving Auto injectors.
One Standard for injectors that inject none lifesaving drugs(like Otrexup for instance)
And one standard for injecting live saving drugs( EPI for instance)
So what you are trying to imply is that somehow FDA thinks that a wonky injector is not really a big deal unless you are using it for a life saving drug.
I find that very hard to believe, surely they only have one criteria laid out for approving Auto Injectors.
But Whogo/icantrade says they have at lest two so where are they?
"" i bet it's in Mylan's filing""
Bet what is in a Myan filing? The FDA guidelines of injector approval guidelines?
Or is it just whogos way of saying, I dont really know where I got that idea from............
Sorry I dont want to put unnecessary strain on your brain. But it's presumably it's in there that you have dreamed up this dual standard theory of yours. Unless off course you have actually seen an FDA document stating, we have two standards for evaluating the safety and security of AI's.
Or is it just a dream child of one of your personas?
You keep posting that any A/B rated competition to Mylans injector will be judged by a Higher Standard By the FDA because it's a Life saving Injector.
Two questions comes to mind.
A. Can you please refer to the FDA documents that states that they are judging injector safety and functionality by two different standards based on what medicine they are supposed to inject.
B. The NDA injectors for competing non A/B product are presumably then judged by a lower standard?
Are they not considered life saving?
Apparently the market thinks they are paying to much for Meda. Anyhow looks like Teva should unload any Mylan shares for whatever they can get, assuming they have any left.
By the way no one has said anything about a problem with the injector so I dont know why you post""nam: nobody's saying there's a problem with the AI""
So there are how many syringe manufacturers out there. Trying so somehow associate Adamis problem with Teva EPi seems incredibly far-fetched to me (obviously not to you).
Why the Teva syringe? Why not the Mylan syringe or any of the other countless syringes out there?
Recall/CRL I'm not sure why you post that,it does not matter.
Give me a connection between Teva and Adamis that will logically make you suspect that their syringes have the same problem. That was my original problem with Hofnos theory and now yours since you are in agreement with him.
How many syringe manufacturers is there. Why should the Syringe Teva uses have the same problem as Adamis syringe? That would be a bit like Volvo being suspected of having airbag problems even if none are reported because Toyota has airbag problems....never mind that Toyota have a different manufacturer of the airbag. If there is no connection Betveen the Adamis syringe and the Teva syringe. Using your impeccable logic why would the Adamis recall have anything to do with anything regarding Teva and I mean anything at all.
RENAISSANCE TECHNOLOGIES LLC 12/31/2015 1,385,438 1,096,397 379.32
The Adamis injector has some sort of virus that has spread to one other device in the world namely the injector that Teva uses.
Who makes the syringe that Teva uses?
Should that logic not be applied to all syringes then? Only these two?
Why is OTREXUP no affected?
I guess you missed my post in December after the when I said something like.
With these numbers brake even looks like Q4 2016.
But well have to wait and see what the numbers are on the coming CC since there was a nice Jump in December and a very good explanation for the dip in November.
Really things change with time and updated data. Well, you seem to be the exception........
Once an ..................Always an ..........
ACAD is from 50 to 17 if you wnrt to use the same timeframe as whogo.
Ryman how is you 22.50 investmen in ACAD going?